This alarming trend has led to a heightened demand for effective pharmacological interventions, particularly GLP-1 receptor agonists, which have demonstrated efficacy in weight loss and glycemic control
While there isnt solid evidence that human requirements for B12 exceed the RDA, meeting the EFSA will put any vegan on par with most omnivores and should ensure optimal B12 status for anyone without suspected abnormal B12 metabolism
However, these medications arent right for everyone
In real-world practice, the stacking conversation often blurs three very different categories: FDA-approved peptide drugs (e.g., tesamorelin for HIV-associated lipodystrophymore on this below) (FDA Access Data) Non-approved peptides sometimes discussed in compounding/wellness circles (e.g., AOD-9604, BPC-157, CJC-1295, ipamorelin) Unregulated research use only products sold online (which often have the worst quality and highest risk) That distinction matters because safety isnt just about pharmacologyits also about purity, stability, sterility, and labeling accuracy
